Dr. Mohamed Khan
Tel: 604-877-6000 ext. 2657
- Leader of Radiation Oncology (regional Professional Practice Leader), British Columbia Cancer Agency - Vancouver Centre
- Associate Professor, University of British Columbia (UBC), Department of Surgery, Division of Radiation Oncology and Developmental Radiotherapeutics
- Director of Research Synergy, British Columbia Cancer Agency & University of British Columbia, Division of Radiation Oncology and Developmental Radiotherapeutics
- Senior Research Scientist, British Columbia Cancer Research Centre (BCCRC), Department of Experimental Therapeutics
- Medical Doctor (Medicine), University of Chicago, United States, 1994
- Doctor of Philosophy (Biochemistry & Molecular Biology), University of California, United States, 1993
- Masters of Science (Honours in Biochemistry), University of Chicago, United States, 1984
- Bachelor in Science (Honours in Chemistry), University of Chicago, United States, 1984
- Post Doctoral Fellow (Fellowship in Surgical Research), Harvard University, Children’s Hospital, Massachusetts, United States, 1997-1999
Clinical Fellow - Residency in Radiation Oncology, Harvard-Joint Center for Radiation Therapy (Brigham and Womens Hospital, Beth Israel-Deaconess Medical Center, Children's Hospital), Boston, Massachusetts, United States, 1995-1999
- Fellow (Internship in Internal Medicine & Surgery), Newton-Wellesley Hospital, Massachusetts, United States, 1994-1995
Dr. Khan is the Leader of Radiation Oncology at the BCCA-Vancouver Centre, part of the British Columbia Cancer Agency (BCCA), and a member of the Provincial Leadership Team for Radiation Oncology. He is also the Director of Research Synergy, which develops research programs between the BCCA and the University of British Columbia (UBC) for the Division of Radiation Oncology. The Vancouver Centre is a large academic cancer centre for the BCCA, located in downtown Vancouver. Over 4300 cancer patients are seen each year by greater than 20 radiation oncology physician faculty with disease site specialization, together with a large multidisciplinary team of physicists, nurses, radiation therapists, clerks and many others within Radiation Oncology, all part of the even larger multidisciplinary teams at the BCCA-Vancouver Centre.
Dr. Khan is a practicing physician as well as a translational researcher, with a laboratory in the BCCRC (BC Cancer Research Center). His primary research interests include the development of nanodevices for improved imaging and treatment of cancer (with significant emphasis in pancreatic, breast, liver and lung cancers), as well as the integration of anti-angiogenic agents and other novel biologics into radiation therapy. The research is highly translational, with the goal of moving rapidly from the bench top to the bedside of cancer patients.
Dr. Khan has significant public policy experience, including being a former long-term member and then Chair of the Council on Science and Public Health (CSAPH) for the American Medical Association (AMA). He currently serves on the Institute of Medicine (IOM-National Academy of Sciences) Roundtable on “Translating Genomic-based Research for Health”, and he is on the Steering Committee of the BC Personalized Medicine Initiative, engaging physicians and scientist throughout BC in what we believe will be the future models of medical care.
Dr. Khan carried out his M.D. and Ph.D. training concurrently, receiving a Ph.D. in Biochemistry and Molecular Biology from the University of California, Santa Barbara and an M.D. from The University of Chicago-Pritzker School of Medicine. He proceeded to do his residency training at the Harvard’s Joint Center for Radiation Therapy (JCRT), and then proceeded on to be a physician-scientist at the University of Michigan. He next was the Director of Basic and Translational Radiation Research, Director of the NanoBiotechnology Center, and Residency Director at Roswell Park Cancer Institute and a tenured Associate Professor at the University of Buffalo-SUNY, prior to moving to the BCCA and UBC.